Preferential selection of receptor-binding variants of influenza virus hemagglutinin by the neutralizing antibody repertoire of transgenic mice expressing a human immunoglobulin μ minigene

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2600-2605

  Laeeq, Sabahat ^a   Smith, Claire A ^a   Wagner, Simon D ^b   Thomas, D Brian ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY; NEOGLYCOPROTEIN; NEUTRALIZING ANTIBODY; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SEQUENCE; IMMUNIZATION; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; TRANSGENIC MOUSE; VIRUS NEUTRALIZATION;

EID: 0030896808     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2600-2605.1997     Document Type: Article

References (22)

1. Bizebard, T., B. Gigant, P. Rigolet, B. Rasmussen, O. Diat, P. Bösecke, S. A. Wharton, J. J. Skehel, and M. Knossow. 1995. Structure of influenza virus hernagglutinin complexed with a neutralising antibody. Nature 376:92-95.
2. b family of antibodies: somatic mutation evident in a γ2a variable region. Cell 24:625-637.
3. Bruggemann, M., H. M. Caskey, C. Teale, H. Waldman, G. T. Williams, M. Azim Surani, and M. S. Neuberger. 1989. A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. Proc. Natl. Acad. Sci. USA 86:6709-6713.
4. Daniels, R. S., A. R. Douglas, J. J. Skehel, and D. C. Wiley. 1983. Analyses of the antigenicity of influenza hemagglutinin at the pH optimum for virus-mediated membrane fusion. J. Gen. Virol. 64:1657-1662.
5. Daniels, R. S., S. Jeffries, P. Yates, G. C. Schild, G. N. Rogers, J. C. Paulson, S. A. Wharton, A. R. Douglas, J. J. Skehel, and D. C. Wiley. 1987. The receptor-binding and membrane fusion properties of influenza virus variants selected using anti-hemagglutinin monoclonal antibodies. EMBO J. 6:1459-1465.
6. Eisen, H. N., and G. W. Siskind. 1964. Variation in affinities of antibodies during the immune response. Biochemistry 3:996-1008.
7. Fazekas de St. Groth, S. 1977. Antigenic, adaptive and adsorptive variants of the influenza A haemagglutinin. Top. Infect. Dis. 3:25-48.
8. Hay, A. (World Influenza Centre, National Institute for Medical Research). Personal communication.
9. Kaartinen, M., G. M. Griffiths, A. F. Markham, and C. Milstein. 1983. mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification. Nature 304:320-324.
10. Patera, A. C., C. M. Graham, D. B. Thomas, and C. A. Smith. 1995. Immunodominance with progenitor B cell diversity in the neutralising antibody repertoire to influenza infection. Eur. J. Immunol. 25:1803-1809.
11. Regers, G. N., J. C. Paulson, R. S. Daniels, J. J. Skehel, I. A. Wilson, and D. C. Wiley. 1983. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304:76-78.
12. Roost, H.-P., M. F. Bachmann, A. Haag, U. Kalinke, V. Pliska, H. Hengartner, and R. M. Zinkernagel. 1995. Early high affinity neutralising anti-viral IgG responses without further overall improvements of affinity. Proc. Natl. Acad. Sci. USA 92:1257-1261.
13. Roth, M. G., R. W. Compans, L. Giusti, A. R. Davis, D. P. Nayak, M.-J. Gething, and J. Sambrook. 1983. Influenza virus hemagglutinin expression is polarised in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell 33:435-443.
14. Smith, C. A., B. C. Barnett, D. B. Thomas, and F. Temoltzin-Palacios. 1991. Structural assignment of novel and immunodominant antigenic sites in the neutralising antibody response of CBA/ Ca mice to influenza hemagglutinin. J. Exp. Med. 173:953-959.
15. Stephens, E. B., R. W. Compans, P. Earl, and B. Moss. 1986. Surface expression of viral glycoproteins is polarised in epithelial cells infected with recombinant vaccinia viral vectors. EMBO J. 5:237-245.
16. Temoltzin-Palacios, F., and D. B. Thomas. 1994. Modulation of immunodominant sites in influenza hemagglutinin compromise antigenic variation and select receptor-binding variant viruses. J. Exp. Med. 179:1719-1724.
17. Wagner, S. D., G. T. Williams, T. Larson, M. S. Neuberger, D. Kitamura, K. Rajewsky, J. Xian, and M. Bruggemann. 1994. Antibodies generated from human immunoglobulin miniloci in transgenic mice. Nucleic Acids Res. 22:1389-1393.
18. Wagner, S. D., A. V. Popov, S. L. Davies, J. Xian, M. S. Neuberger, and M. A. Bruggemann. 1994. The diversity of antigen-specific monoclonal antibodies from transgenic mice bearing human immunoglobulin gene miniloci. Eur. J. Immunol. 24:2672-2681.
19. Weis, W., J. H. Brown, S. Cusack, J. C. Paulson, J. J. Skehel, and D. C. Wiley. 1988. Structure of the influenza virus hemagglutinin complexed with its receptor, sialic acid. Nature 333:426-431.
20. Wiley, D. C., I. A. Wilson, and J. J. Skehel. 1981. Structural identification of the antibody binding sites of Hong Kong influenza HA and their involvement in antigenic variation. Nature 289:373-378.
21. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366-373.
22. Yewdell, J. W., A. J. Caton, and W. Gerhard. 1986. Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J. Virol. 57:623-628.